Body Composition & GH Pathways
Tesamorelin
A GHRH analogue widely recognised in body-composition and growth-hormone pathway discussions.
Weight Management
A triple-pathway peptide attracting exceptional interest across metabolic health and weight-management markets.
Retatrutide is a multi-receptor peptide designed to engage GLP-1, GIP, and glucagon pathways. Its differentiated triple-agonist profile has made it one of the most closely followed products in the next generation of metabolic and body-weight research. For professional buyers, that recognition creates strong category awareness and a clear need for accurate product identification, strength selection, and private supply discussion.
Retatrutide brings three metabolic signalling pathways into one peptide profile. That combination differentiates it from single- and dual-pathway products and drives interest among buyers building forward-looking weight-management catalogues.
Strength, current availability, batch information, packaging options, MOQ, and wholesale quotation are confirmed privately.
Retatrutide is listed in 15 MG and 20 MG. Strength, current availability, batch information, packaging options, MOQ, and wholesale quotation are confirmed privately.
Available documents may include COA, HPLC, LC-MS, purity, sequence, molecular weight, MSDS, origin information, and third-party reports. Document availability varies by product and batch. Request the specific product and strength you are evaluating so our team can share the most relevant current information.
Request COARetatrutide is listed in 15 mg and 20 mg strengths.
Yes. Select the required strength and request the currently available product documents.
No. Wholesale pricing is provided privately based on strength, volume, destination, and programme requirements.
Share your company, destination, expected order range, and preferred documents. Our team will respond through your preferred contact channel.